Sao H, Kitaori K, Kasai M, Shimokawa T, Kato H, Hayakawa M, Kato C, Yamaguchi T, Kamiya Y, Yanada M, Morishima Y
Hematology and Bone Marrow Transplantation Center, Meitetsu Hospital.
Rinsho Ketsueki. 1998 Jul;39(7):473-80.
Fifty leukemia patients were given bone marrow transplants (BMTs) from unrelated donors at Meitetsu Hospital. We studied the outcomes of their transplants from two perspectives: leukemia disease stage and acute graft versus host disease (GVHD). The probability of disease-free survival for standard-risk, high-risk, and super-high risk patients was 65%, 29%, and 8%, respectively. The main causes of death were septicemia, cardiac and renal failure, and relapse of leukemia in the high- and super-high risk patients, and grade III-IV acute GVHD in the standard-risk patients. The incidence of grade II-IV and grade III-IV acute GVHD was 32% and 17%, respectively. All 7 patients in whom grade III-IV severe acute GVHD developed died. We conclude that better control of acute GVHD and treatment of early stage complications are clearly important to improving the outcome of BMTs from unrelated donors, especially for high and super-high risk patients.
五十名白血病患者在名铁医院接受了来自无关供体的骨髓移植(BMT)。我们从两个角度研究了他们移植的结果:白血病疾病阶段和急性移植物抗宿主病(GVHD)。标准风险、高风险和超高风险患者的无病生存率分别为65%、29%和8%。高风险和超高风险患者的主要死亡原因是败血症、心脏和肾衰竭以及白血病复发,标准风险患者的主要死亡原因是III-IV级急性GVHD。II-IV级和III-IV级急性GVHD的发生率分别为32%和17%。发生III-IV级严重急性GVHD的所有7名患者均死亡。我们得出结论,更好地控制急性GVHD和治疗早期并发症显然对于改善来自无关供体的BMT结果很重要,特别是对于高风险和超高风险患者。